Thank you for your interest in applying for the Bayer Hemophilia Awards Program. This program represents Bayer's continuing commitment to taking the next steps for the next generation of people with hemophilia to enjoy a better quality of life and treatment options.

Applications will be processed solely through the Internet and all applications must be submitted in English.

As a first step, applicants should submit a Letter of Intent describing the proposed project in 500 words or fewer. All Letters of Intent submitted will receive an e-mail confirming receipt.

Letters of Intent will be reviewed by all 13 members of the Grants Review and Awards Committee. In some cases, additional information may be requested.

Selected applicants will be invited to submit a full proposal that will be reviewed by at least two members of the Grants Review and Awards Committee. These applicants will be e-mailed a full application form.

The results of the review process and funding decisions will be communicated to applicants in May each year. Funded applicants must send a letter of acceptance and enter into an agreement outlining obligations and understandings prior to disbursement of funds.

Awardees will be invited to attend an Awards Dinner that will coincide with the bi-annual meetings of the World Federation of Hemophilia (WFH) or the International Society for Thrombosis and Hemostasis (ISTH).

The table below summarizes the application timelines for 2010/11.

Action	Date
LOI submissions	Permitted throughout year
Deadline for consideration	November 30, 2010
GRAC reviews LOIs	December 2010/January 2011
GRAC informs applicants	January 31, 2011
Applicants develop proposals	February/March 2011
Full Proposals submitted	March/April 2011
GRAC reviews Full Proposals	May 2011
Applicants notified of GRAC decisions	May/June 2011
Funding available	August 2011